CA Patent

CA2628659A1 — Combinations and methods of using an immunomodulatory oligodeoxynucleotide

Assigned to Individual · Expires 2007-05-24 · 19y expired

What this patent protects

The present invention relates to combination therapies for the treatment of cancer. The combination of agents include oligonucleotides and one or more chemotherapeutic agents.

USPTO Abstract

The present invention relates to combination therapies for the treatment of cancer. The combination of agents include oligonucleotides and one or more chemotherapeutic agents.

Drugs covered by this patent

Camptosar (Irinotecan Hydrochloride) · Pfizer

Patent Metadata

Patent number: CA2628659A1
Jurisdiction: CA
Classification: —
Expires: 2007-05-24
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.